Tests a robot-assisted method for brain blood vessel procedures
Tests a robotic device during brain blood vessel procedures in adults with stroke or meningioma.
Plain-language title generated from the registry record
Registry title: Robot-Assisted Neurovascular Intervention
Key facts
- Where
- Seoul, South KoreaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06752096, who can take part
Where in South Korea
- Severence Hospital, Yonsei University College of MedicineSeoul, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Navigantis Inc.
- Trial code
- NCT06752096
- Record updated
- 16 January 2026
- Original description
Patients scheduled for neurovascular interventions may be eligible to have their procedure done robotically.Read full original descriptionShow less
Robot-assisted Neurovascular Intervention for Patients Indicated for Angiography, Cerebral Artery Embolization, and Thrombectomy: Exploratory Study to Compare to Existing Interventional Procedures
Patients scheduled for neurovascular interventions may be eligible to have their procedure done robotically.
Inclusion: Patients scheduled for neurovascular interventions, such as diagnostic cerebral angiography for cerebrovascular diseases, arterial embolization for meningioma treatment, and thrombectomy for thrombotic arterial occlusion-induced cerebral ischemia, are selected according to the same criteria as standard cerebral angiography and interventional procedures.
Exclusion: Patients who have undergone surgery within 4 weeks prior to study participation or have not fully recovered from surgery; Patients with a history of cardiac events, such as myocardial infarction or superior vena cava (SVC) syndrome, within 3 months prior to study participation, or with existing heart disease; Patients where the intracranial occlusion is determined to be chronic based on clinical history, prior imaging, or clinical judgment; Patients with existing or anticipated vasospasm, bleeding, or severe atheromatous disease; Patients allergic to contrast agents used in angiography; Patients with renal failure; Patients suspected to have cerebral artery dissection or atherosclerosis as the cause of stroke; Patients who are pregnant or breastfeeding; Patients unable to cooperate due to difficulty in expressing intent to the extent that the procedure cannot proceed; Patients with severe or life-threatening comorbidities that could significantly affect symptom improvement or render the procedure unbeneficial; Patients with non-life-threatening comorbidities that prevent proper follow-up for treatment; Patients with an ASPECTS score of 0-2 on a pre-treatment non-contrast CT; Inability to perform femoral puncture within 60 minutes of completing CT angiography (if CT perfusion is performed, it must be done after CT angiography); Absence of a femoral pulse; Cases where vascular access is highly challenging, with an anticipated time exceeding 90 minutes from CT angiography to reperfusion.